There are currently no generic Copaxone (glatiramer acetate) products licensed for sale. Copaxone is under the protection of patents that prevent any generic versions from being manufactured in the United States. When the first patent expires in May 2014, other companies can begin producing a generic Copaxone drug. In the meantime, so-called generic versions of the drug online should be avoided.
Copaxone® (glatiramer acetate) is a prescription medication used to treat multiple sclerosis (also known as MS). It is part of a group of medications known as interferons and must be taken by injection.
Copaxone is manufactured by Teva Neuroscience, Inc. It is currently under the protection of several patents that prevent any generic Copaxone from being manufactured or sold in the United States. Yet, if you search the Internet for "generic Copaxone," you may find a number of companies selling it. The fact is that these medicines may be fake, substandard, and potentially dangerous. Generic Copaxone may be available from another country, but there is really no way of knowing whether you are actually getting genuine Copaxone. You should not buy any generic Copaxone until there is an approved version available.
The first patent for Copaxone currently expires in May 2014. This is the earliest possible date that a generic version of the drug could become available. However, other circumstances could come up to extend the exclusivity period beyond 2014. This could include such things as other patents for specific Copaxone uses or lawsuits. Once the patent expires, several companies will likely begin manufacturing a generic Copaxone drug.